A Study of LY5625575 in Healthy Participants and in Participants With Inflammation (Elevated C-Reactive Protein)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The main purpose of this study is to evaluate the safety and tolerability of LY5625575 inhealthy participants (including Japanese and Chinese) and in participants with highlevels of a marker for inflammation (C‐reactive protein). The study will also measure howmuch LY5625575 gets into the bloodstream and how long it takes the body to get rid of it.The study will last seven to nine weeks.
Epistemonikos ID: 1dc8ebecfc2f9cfd4c1a6196208d4210e94df1b4
First added on: Sep 03, 2026